Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland.
Profound Medical stock last closed at $6.20, up 12.73% from the previous day, and has decreased 17.77% in one year. It has overperformed other stocks in the Medical Devices industry by 0.16 percentage points. Profound Medical stock is currently +64.89% from its 52-week low of $3.76, and -32.39% from its 52-week high of $9.17.
At the moment, there are 30.05M PROF shares outstanding. The market capitalization of PROF is $186.33M. In the last 24 hours, 69,600 PROF shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy PROF stock.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, it's time to fill out some personal info so you can buy PROF today.
Now that you have finished signing up on one of the most highly reviewed stock apps, you need to deposit funds:
Check out the video below to see the process of depositing funds into your new investment account.
After you have figured out the best place to buy Profound Medical stock, it's absolutely critical to research their stock before you buy, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on PROF's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge PROF's fair value.
Using relative valuations methods:
You can access more valuation analysis on PROF's stock here.
You can dig deeper into what analysts are forecasting on the Profound Medical stock forecast page.
Last year, PROF revenue was $8.30M. In the past five year, PROF's revenue has gone up by 21.23% per year. This was faster than the Medical Devices industry average of 10.62%.
Learn more about PROF's earnings and revenue performance here.
In the past year, executives and large shareholders at PROF have bought more shares than they have sold.
Arun Swarup Menawat, CEO of PROF, was the latest PROF insider to buy. They bought $56,887.71 worth of PROF shares on May 16, 2025.
Get more info about who owns PROF stock here.
No, Profound Medical doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main options:
Click the Open button and your broker will execute your order.
If you want more help investing in stocks on eToro, click the how to video below:
Now that you own some PROF shares, you'll want to keep up with your shares.
Make a watchlist to keep tabs on your PROF stock.
To summarize, here are the 6 steps to buy stock in Profound Medical:
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Profound Medical, get started below.